Health Economics

Estimating the causal effect of genetic liability to prevalent disease on hospital costs using Mendelian Randomization
Padraig Dixon, Sean Harrison, William Hollingworth, Neil M Davies, George Davey Smith

medRxiv 2020.07.09.20149906; doi: https://doi.org/10.1101/2020.07.09.20149906

Add to Selected Citations
A Poorly Understood Disease? The Unequal Distribution of Excess Mortality Due to COVID-19 Across French Municipalities^*
Paul Brandily, Clément Brébion, Simon Briole, Laura Khoury

medRxiv 2020.07.09.20149955; doi: https://doi.org/10.1101/2020.07.09.20149955

Add to Selected Citations
COVID-19 incidence trends between April and June 2020: A global analysis
Vincent Amanor-Boadu, Kara Ross

medRxiv 2020.07.07.20148007; doi: https://doi.org/10.1101/2020.07.07.20148007

Add to Selected Citations
The socio-economic determinants of COVID-19: A spatial analysis of German county level data
Andree Ehlert

medRxiv 2020.06.25.20140459; doi: https://doi.org/10.1101/2020.06.25.20140459

Add to Selected Citations
Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation
Edward M. Hill, Stavros Petrou, Henry Forster, Simon de Lusignan, Ivelina Yonova, Matt J. Keeling

medRxiv 2020.03.21.20040568; doi: https://doi.org/10.1101/2020.03.21.20040568

Add to Selected Citations
Forecasting the Number of Coronavirus (COVID-19) Cases in Ethiopia Using Exponential Smoothing Times Series Model
Teshome Hailemeskel Abebe

medRxiv 2020.06.29.20142489; doi: https://doi.org/10.1101/2020.06.29.20142489

Add to Selected Citations
Beta regression with spatio-temporal effects as a tool for hospital impact analysis of initial phase epidemics: the case of COVID-19 in Spain
Gil Jannes, Jesús Barreal

medRxiv 2020.06.27.20141614; doi: https://doi.org/10.1101/2020.06.27.20141614

Add to Selected Citations
Face Masks Considerably Reduce Covid-19 Cases in Germany
Timo Mitze, Reinhold Kosfeld, Johannes Rode, Klaus Wälde

medRxiv 2020.06.21.20128181; doi: https://doi.org/10.1101/2020.06.21.20128181

Add to Selected Citations
Cost Benefit Analysis of Limited Reopening Relative to a Herd Immunity Strategy or Shelter in Place for SARS-CoV-2 in the United States
Robert B. Schonberger, Yair J. Listokin, Ian Ayres, Reza Yaesoubi, Zachary R. Shelley

medRxiv 2020.06.26.20141044; doi: https://doi.org/10.1101/2020.06.26.20141044

Add to Selected Citations
The effect of reopening policy on COVID-19 related cases and deaths
Qiyao Zhou

medRxiv 2020.06.25.20139840; doi: https://doi.org/10.1101/2020.06.25.20139840

Add to Selected Citations

Health Economics

Pages